Table 1 Overall antimicrobial consumption by the patient demographics, ICU type, and type of antimicrobials prescribed
| Â | Sum of DOT during the study | |
|---|---|---|
Value | % | |
Overall | 30,110 | 100.00 |
Age | ||
 First month | 10,311 | 34.2 |
 1–12 months | 11,822 | 39.3 |
 1–16 years | 7977 | 26.4 |
Gender | ||
 Male | 16,076 | 53.4 |
 Female | 14,020 | 46.6 |
Type of ICU | ||
 Pediatric general | 10,249 | 34.0 |
 Pediatric cardiothoracic | 8075 | 26.8 |
 Neonatal | 11,786 | 39.1 |
Antimicrobials | ||
 Amikacin | 3608 | 12.0 |
 Gentamicin | 3361 | 11.2 |
 Imipenem | 4 | 0.0 |
 Meropenem | 3543 | 11.8 |
 Ceftriaxone | 1411 | 4.7 |
 Cefotaxime | 3671 | 12.2 |
 Ceftazidime | 5427 | 18.0 |
 Cefepime | 43 | 0.1 |
 Ciprofloxacin, IV | 632 | 2.1 |
 Ciprofloxacin, oral | 14 | 0.0 |
 Norfloxacin, IV | 1 | 0.0 |
 Piperacillin/tazobactam | 1654 | 5.5 |
 Vancomycin, IV | 5615 | 18.6 |
 Vancomycin, oral | 5 | 0.0 |
 Colistin | 264 | 0.9 |
 Caspofungin | 431 | 1.4 |
 Amphotericin B | 426 | 1.4 |
Route | ||
 Intravenous | 30,084 | 99.9 |
 Oral | 26 | 0.1 |